- Product NDC
- 43742-1507
- 11-digit product format
- 437421507
- Labeler code
- 43742
- Product ID
- 43742-1507_98b646e4-e71f-46d3-9094-778235b7af46
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Lilium Tigrinum, Bovista, Cypripedium Pubescens, Hydrastis Canadensis, Petroselinum Sativum, Aquilegia Vulgaris, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Heart (Suis), Kreosotum, Oophorinum (Suis), Uterus (Suis), Folliculinum, Lachesis Mutus, Magnesia Phosphorica, Mercurius Solubilis, Sepia, Pineal Gland (Suis), Hypophysis Suis, Aconiticum Acidum CIS-, Apis Venenum Purum, Estradiol, Progesterone, Testosterone, Placenta Totalis Suis, Faecalis (Alkaligenes), Mutabile Bacillus (Bach)
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- Deseret Biologicals, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2019-08-20
- Marketing end
- 2030-01-02
- Substance
- ACONITIC ACID, (Z)-; ALCALIGENES FAECALIS; APIS MELLIFERA VENOM; AQUILEGIA VULGARIS; CYPRIPEDIUM PARVIFLORUM VAR. PUBESCENS ROOT; ESCHERICHIA COLI; ESTRADIOL; ESTRONE; GOLDENSEAL; LACHESIS MUTA VENOM; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOPERDON UTRIFORME FRUITING BODY; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MERCURIUS SOLUBILIS; PETROSELINUM CRISPUM WHOLE; PORK HEART; PROGESTERONE; SEPIA OFFICINALIS JUICE; SUS SCROFA ADRENAL GLAND; SUS SCROFA OVARY; SUS SCROFA PINEAL GLAND; SUS SCROFA PITUITARY GLAND; SUS SCROFA PLACENTA; SUS SCROFA UMBILICAL CORD; SUS SCROFA UTERUS; TESTOSTERONE; WOOD CREOSOTE
- Active strength
- 10; 30; 18; 8; 6; 30; 30; 8; 6; 10; 4; 6; 10; 12; 6; 8; 30; 13; 8; 8; 16; 10; 6; 8; 8; 30; 8 [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
- Pharmacologic classes
- Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Calculi Dissolution Agent [EPC], Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Progesterone [CS], Progesterone [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
- DEA schedule
- CIII
- NDC exclude flag
- No
- Current FDA listing
- Yes